Home » Topics » Regulatory

Regulatory
RSS

FDA grants manufacturing approval for bulk ciclosporin

July 8, 1997

Update on DepoTech's DepoCyt

July 8, 1997

IVAX's generic estazolam cleared for marketing by FDA

July 8, 1997

Royce Laboratories' generic meperidine approved by FDA

July 8, 1997

Novopharm granted final approval by U.S. Federal Court to market generic Zantac

July 7, 1997

Sublingual captopril and nifedipine compared in patients with hypertensive crises

July 7, 1997

Cholinesterase inhibition with metrifonate studied in rats

July 4, 1997

Hyal's treatment for sun spots approved in the U.K.

July 3, 1997

FDA approves Mirapex for the treatment of Parkinson's disease

July 3, 1997

Rebamipide for diabetic nephropathy

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....